Previous close | 39.57 |
Open | 40.84 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 40.84 - 41.27 |
52-week range | 40.84 - 41.27 |
Volume | |
Avg. volume | N/A |
Market cap | 6.685B |
Beta (5Y monthly) | 1.32 |
PE ratio (TTM) | 14.84 |
EPS (TTM) | 2.78 |
Earnings date | 21 Feb 2022 - 25 Feb 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Endo (ENDP) plunges on reports of negotiations with its lenders and senior bondholders about a possible restructuring of more than $8 billion of debt.
We provide five reasons, which make Halozyme (HALO) a good investment option in 2022.